Fennec Pharmaceuticals Inc. (FENC)

NASDAQ: FENC · Real-Time Price · USD

8.49

-0.12 (-1.39%)

At close: Feb 27, 2026, 4:00 PM EST

8.50

+0.01 (0.12%)

After-hours: Feb 27, 2026, 4:10 PM EST

Fennec Pharmaceuticals Market Cap

Fennec Pharmaceuticals has a market cap or net worth of $289.96 million as of February 27, 2026. Its market cap has increased by 62.08% in one year.

Market Cap

289.96M

Enterprise Value

287.39M

1-Year Change

62.08%

Ranking

#3544

Market Cap Chart

Since December 31, 2004, Fennec Pharmaceuticals's market cap has increased from $65.80M to $289.96M, an increase of 340.67%. That is a compound annual growth rate of 7.26%.

Market Cap History

Date	Market Cap	% Change
Feb 27, 2026	238.70M	10.25%
Dec 31, 2025	216.50M	24.86%
Dec 31, 2024	173.40M	-41.97%
Dec 29, 2023	298.80M	18.62%
Dec 30, 2022	251.90M	120.19%
Dec 31, 2021	114.40M	-40.51%
Dec 31, 2020	192.30M	48.95%
Dec 31, 2019	129.10M	2.54%
Dec 31, 2018	125.90M	-20.82%
Dec 29, 2017	159.00M	444.52%
Dec 30, 2016	29.20M	53.68%
Dec 31, 2015	19.00M	-28.30%
Dec 31, 2014	26.50M	208.14%
Dec 31, 2013	8.60M	-34.35%
Dec 31, 2012	13.10M	61.73%
Dec 30, 2011	8.10M	-55.98%
Dec 31, 2010	18.40M	260.78%
Dec 31, 2009	5.10M	-
Dec 31, 2008	5.10M	-85.26%
Dec 31, 2007	34.60M	138.62%
Dec 29, 2006	14.50M	-51.67%
Dec 30, 2005	30.00M	-54.41%
Dec 31, 2004	65.80M	-

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Protara Therapeutics	309.20M
ALX Oncology Holdings	308.31M
Nautilus Biotechnology	305.66M
Neurogene	304.84M
Cellectis	299.44M
AC Immune	292.87M
Inhibikase Therapeutics	285.88M
X4 Pharmaceuticals	284.17M

Market Cap Rankings